Additional COVID-19 Booster Doses Increase Anti-spike Serum Antibody Concentrations Among Patients With Inflammatory Bowel Disease

Affiliations

¹ University of Wisconsin School of Medicine and Public Health, Department of Internal Medicine, Madison, Wisconsin, USA.
² Mayo Clinic, Division of Gastroenterology & Hepatology, Inflammatory Bowel Disease Center, Jacksonville, Florida, USA.
³ University of Wisconsin-Madison, School of Pharmacy, Madison, Wisconsin, USA.
⁴ University of Wisconsin School of Medicine and Public Health, Department of Internal Medicine, Division of Gastroenterology & Hepatology, Madison, Wisconsin, USA.

Comment

Trevor L Schell et al. Inflamm Bowel Dis. 2023.

. 2023 Oct 3;29(10):e38-e39.

doi: 10.1093/ibd/izad068.

¹ University of Wisconsin School of Medicine and Public Health, Department of Internal Medicine, Madison, Wisconsin, USA.
² Mayo Clinic, Division of Gastroenterology & Hepatology, Inflammatory Bowel Disease Center, Jacksonville, Florida, USA.
³ University of Wisconsin-Madison, School of Pharmacy, Madison, Wisconsin, USA.
⁴ University of Wisconsin School of Medicine and Public Health, Department of Internal Medicine, Division of Gastroenterology & Hepatology, Madison, Wisconsin, USA.

No abstract available

Comment on

Effect of 2 vs 3 Doses of COVID-19 Vaccine in Patients With Inflammatory Bowel Disease: A Population-based Propensity Matched Analysis.
Desai A, Deepak P, Cross RK, Murone J, Farraye FA, Ungaro RC, Kochhar GS. Desai A, et al. Inflamm Bowel Dis. 2023 Oct 3;29(10):1563-1571. doi: 10.1093/ibd/izac252. Inflamm Bowel Dis. 2023. PMID: 36576102